These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30689421)

  • 1. Response by Kikuchi et al Regarding Article, "Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target".
    Kikuchi N; Satoh K; Saito Y; Shimokawa H
    Circulation; 2019 Jan; 139(5):724-725. PubMed ID: 30689421
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Schomburg and Melander Regarding Article, "Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target".
    Schomburg L; Melander O
    Circulation; 2019 Jan; 139(5):722-723. PubMed ID: 30689424
    [No Abstract]   [Full Text] [Related]  

  • 3. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small SeP or Giant Leap for Pulmonary Hypertension Research?
    Bonnet S; Paulin R; Boucherat O
    Circulation; 2018 Aug; 138(6):624-626. PubMed ID: 30354625
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Chen
    Provencher S; Boucherat O; Berger RMF; Goumans MJ; Bonnet S
    Am J Respir Crit Care Med; 2020 May; 201(10):1313-1314. PubMed ID: 32032495
    [No Abstract]   [Full Text] [Related]  

  • 6. Selenoprotein P - a new player in PAH.
    Fernández-Ruiz I
    Nat Rev Cardiol; 2018 Jul; 15(7):381. PubMed ID: 29700402
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter by Hernandez-Gonzalez et al Regarding Article, "Phenotypic Characterization of
    Hernandez-Gonzalez I; Navas P; Escribano-Subias P
    Circulation; 2018 May; 137(22):2411-2412. PubMed ID: 29844074
    [No Abstract]   [Full Text] [Related]  

  • 8. Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension.
    Satoh K; Kikuchi N; Kurosawa R; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2019 Aug; 39(8):1504-1506. PubMed ID: 31339778
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter by Nikpour et al Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)".
    Nikpour M; Prior D; Celermajer D
    Circulation; 2016 May; 133(20):e661. PubMed ID: 27185030
    [No Abstract]   [Full Text] [Related]  

  • 10. Response by van der Bruggen et al to Letter Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
    van der Bruggen CE; Happé CM; Goumans MJ; Bogaard HJ; Vonk Noordegraaf A; de Man FS
    Circulation; 2016 Aug; 134(9):e117-8. PubMed ID: 27572883
    [No Abstract]   [Full Text] [Related]  

  • 11. Response by Hadinnapola et al to Letter Regarding Article, "Phenotypic Characterization of
    Hadinnapola C; Gräf S; Morrell NW
    Circulation; 2018 May; 137(22):2413-2414. PubMed ID: 29844075
    [No Abstract]   [Full Text] [Related]  

  • 12. BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?
    Chen L; Liu C; Lu W; Wang T
    Am J Respir Crit Care Med; 2020 May; 201(10):1313. PubMed ID: 32032498
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter by Kataoka et al Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
    Kataoka M; Satoh T; Fukuda K
    Circulation; 2016 Aug; 134(9):e115-6. PubMed ID: 27572882
    [No Abstract]   [Full Text] [Related]  

  • 14. Protease-activated receptor 1 as potential therapeutic target in pulmonary arterial hypertension.
    Merkus D; van Beusekom HMM; Boomars KA
    Cardiovasc Res; 2019 Jul; 115(8):1260-1261. PubMed ID: 30903137
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to Badagliacca et al: Multi-dimensional assessment and cluster analysis for idiopathic pulmonary arterial hypertension phenotyping.
    Hoeper MM; Held M
    J Heart Lung Transplant; 2021 Feb; 40(2):167-168. PubMed ID: 33262004
    [No Abstract]   [Full Text] [Related]  

  • 16. The adrenergic nervous system as a therapeutic target in pulmonary arterial hypertension: a cautionary tale.
    Rubin LJ
    Eur Respir J; 2016 Sep; 48(3):617-8. PubMed ID: 27581405
    [No Abstract]   [Full Text] [Related]  

  • 17. [PRIMARY PULMONARY ARTERIAL HYPERTENSION. APROPOS OF 8 PERSONAL OBSERVATIONS].
    BERNAL P; DESAINT-ALARY J; HEIMDEBALSAC R
    Mal Cardiovasc; 1965; 6():121-38. PubMed ID: 14318785
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to Hou et al.: Can Magnetic Resonance Imaging Effectively Evaluate the Prognosis of Patients with Pulmonary Arterial Hypertension?
    Swift AJ; Wild JM; Kiely DG
    Am J Respir Crit Care Med; 2018 Mar; 197(5):676-677. PubMed ID: 28961018
    [No Abstract]   [Full Text] [Related]  

  • 19. Baloon atrial septostomy in pulmonary arterial hypertension: Atrial flow regulator - New therapeutic option.
    Sabiniewicz R
    Cardiol J; 2017; 24(4):455-456. PubMed ID: 28831783
    [No Abstract]   [Full Text] [Related]  

  • 20. Toward Harnessing Sex Steroid Signaling as a Therapeutic Target in Pulmonary Arterial Hypertension.
    Lahm T; Frump AL
    Am J Respir Crit Care Med; 2017 Feb; 195(3):284-286. PubMed ID: 28145752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.